Joshua Makower
CIK 1235952 · last filed 2022-10-14
Joshua Makower is a corporate insider who has filed 46 SEC Form 4 insider transactions across 18 companies since 2016. The most recent filing, for EAR, was dated Oct 14, 2022. Across all open-market trades the lifetime net is +$218.0M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $459.2M across reported positions. 5 SEC filings were submitted jointly with Forest Baskett.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
BHG price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
MOUNTAIN VIEW, CA 94043
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Eargo, Inc. (EAR) Delisted | Director | 1,500 | $2.57 | $3.9K | $5.60M | 5 | 2022-10-14 |
| NeueHealth, Inc. (BHG) Delisted | 10%+ Owner | 278,608 | $16.35 | $4.56M | $35.00M | 1 | 2021-06-30 |
| GLUE | 10%+ Owner | 5,973,296 | $10.48 | $62.60M | $19.95M | 1 | 2021-06-30 |
| Desktop Metal, Inc. (DM) Delisted | 10%+ Owner | 228 | $4.96 | $1.1K | $0 | 1 | 2021-06-10 |
| MRKR | 10%+ Owner | 1,071,428 | $0.91 | $971.1K | $10.00M | 1 | 2021-03-18 |
| Regulus Therapeutics Inc. (RGLS) Delisted | 10%+ Owner | 645,106 | $8.16 | $5.26M | $3.96M | 3 | 2020-12-07 |
| Metacrine, Inc. (MTCR) Delisted | 10%+ Owner | 1,958,333 | $0.49 | $969.2K | $10.00M | 1 | 2020-09-22 |
| Inozyme Pharma, Inc. (INZY) Delisted | 10%+ Owner | 2,000,533 | $4.00 | $8.00M | $4.00M | 1 | 2020-07-28 |
| GENOCEA BIOSCIENCES, INC. (GNCA) Delisted | 10%+ Owner | 10,376,936 | $0.00 | $6.2K | $21.78M | 3 | 2020-07-28 |
| NKTX | 10%+ Owner | 522,639 | $1.83 | $956.4K | $12.00M | 1 | 2020-07-16 |
| Akouos, Inc. (AKUS) Delisted | 10%+ Owner | 513,758 | $13.29 | $6.83M | $10.00M | 1 | 2020-07-01 |
| AVEO PHARMACEUTICALS, INC. (AVEO) Delisted | 10%+ Owner | 3,952,958 | $15.00 | $59.29M | $24.62M | 16 | 2020-06-22 |
| TRVI | 10%+ Owner | 5,938,562 | $12.51 | $74.29M | $25.00M | 2 | 2020-04-13 |
| ARDX | 10%+ Owner | 3,082,186 | $3.00 | $9.25M | $23.33M | 4 | 2019-12-09 |
| MIRM | 10%+ Owner | 3,736,243 | $83.27 | $311.12M | $6.75M | 1 | 2019-07-24 |
| Oruka Therapeutics, Inc. (ABIO) Delisted | 10%+ Owner | 0 | $28.80 | $0 | -$731.3K | 1 | 2018-02-27 |
| Cascadian Therapeutics, Inc. (CASC) Delisted | 10%+ Owner | 10,882,574 | — | — | $0 | 1 | 2018-02-22 |
| Achaogen, Inc. (AKAO) Delisted | 10%+ Owner | 5,215,128 | — | — | $6.75M | 1 | 2016-12-19 |
Recent Filings
46 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-10-14 | Eargo, Inc. (EAR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-08-25 | Eargo, Inc. (EAR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-06-30 | NeueHealth, Inc. (BHG) Delisted | Mixed | +135,584,859 | $35.00M | EDGAR |
| 2021-06-30 | GLUE | Mixed | +7,692,298 | $19.95M | EDGAR |
| 2021-06-10 | Desktop Metal, Inc. (DM) Delisted | Other (J) | −8,997,715 | $0 | EDGAR |
| 2021-05-26 | Eargo, Inc. (EAR) Delisted | Other (J) | −1,999,492 | $0 | EDGAR |
| 2021-03-18 | MRKR | Buy (P) | +5,714,285 | $10.00M | EDGAR |
| 2020-12-07 | Regulus Therapeutics Inc. (RGLS) Delisted | Buy (P) | +4,398,602 | $2.74M | EDGAR |
| 2020-10-22 | Eargo, Inc. (EAR) Delisted | Mixed | +6,520,017 | $5.60M | EDGAR |
| 2020-10-19 | Eargo, Inc. (EAR) Delisted | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.